一个全面的临床知情地图的依赖性在癌细胞和目标优先级的框架目标优先级的框架
Clare Pacini1, Emma Duncan1, Emanuel Gonçalves2
1Wellcome Sanger Institute, Wellcome Genome Campus, Hinxton, Cambridge CB10 1SA, UK; Open Targets, Wellcome Genome Campus, Hinxton, Cambridge CB10 1SA, UK.
Cancer cell
|January 12, 2024
概括
这项研究利用来自930个细胞系的多奥米克数据绘制了癌症依赖性的地图,确定了新的抗癌标. 这些发现揭示了基因成的驱动因素,并为27种癌症类型优先考虑了370个目标.
科学领域:
- 基因组学就是基因组学.
- 癌症生物学 癌症生物学
- 药物发现 药物发现 药物发现
背景情况:
- 癌症细胞系中的基因选对于理解基因功能和识别药物标至关重要.
- 现有的屏幕数据集往往缺乏全面的多omics数据,限制了遗传漏洞的功能映射.
研究的目的:
- 通过将多omics数据与CRISPR-Cas9查结果集成,构建第二代癌症依赖性地图.
- 确定与癌症依赖相关的新型分子标记物,并探索基因成的驱动因素.
- 通过将依赖性标记器关联与网络分析相结合,优先考虑抗癌目标.
主要方法:
- 有注释的930个癌细胞系与多原子数据.
- 从CRISPR-Cas9屏幕分析了分子标记物和癌症依赖性之间的关系.
- 综合依赖性标记的关联与蛋白质-蛋白质相互作用网络和测序的瘤队列.
主要成果:
- 在已知的驱动基因之外确定了依赖性相关的基因表达标记物.
- 观察到许多基因成关系是由功能增益突变而不是合成致命性驱动的.
- 优先考虑27种癌症类型的370个抗癌标,为许多癌症提供基于网络的功能证据.
- 将优先级目标映射到瘤队列中,在不同癌症类型中确定可处理的目标.
结论:
- 开发的癌症依赖地图增强了对基因依赖和功能基因组学的理解.
- 确定了370个高优先级的抗癌标,为药物开发提供了新的途径.
- 这项工作为精密瘤学和发现新疗法提供了宝贵的资源.
相关概念视频
Adaptive Mechanisms in Cancer Cells
5.8K
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
5.8K
Targeted Cancer Therapies
7.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.6K
Cancer-Critical Genes I: Proto-oncogenes
8.9K
Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
8.9K
Cancer Stem Cells and Tumor Maintenance
4.9K
Early diagnosis and treatment can often cure cancer. However, even with treatment, residual cells called cancer stem cells (CSC) might remain, often causing tumor recurrence. These cancer stem cells possess the potential for self-renewal and multi-lineage differentiation and are often responsible for the therapeutic resistance displayed in most cancers.
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
4.9K
M-Cdk Drives Transition Into Mitosis
5.6K
Checkpoints throughout the cell cycle serve as safeguards and gatekeepers, allowing the cell cycle to progress in favorable conditions and slow or halt it in problematic ones. This regulation is known as the cell cycle control system.
Cyclin-dependent kinases, or Cdks, work in concert with cyclins to control cell cycle transitions. M-Cdk, a complex of Cdk1 bound to M cyclin, is a well-known example of this coordinated control that drives the transition from the G2 to the M phase.
M cyclin...
Cyclin-dependent kinases, or Cdks, work in concert with cyclins to control cell cycle transitions. M-Cdk, a complex of Cdk1 bound to M cyclin, is a well-known example of this coordinated control that drives the transition from the G2 to the M phase.
M cyclin...
5.6K
Combination Therapies and Personalized Medicine
4.9K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.9K


